Carregant...
Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?
Background to the debate: In the United States, the passage of the Bayh–Dole Act in 1980 encouraged universities to license inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibi...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC545202/ https://ncbi.nlm.nih.gov/pubmed/15696219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0020009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|